Opioid Toxicity Versus Uncontrolled Pain in Severe Mucositis
Jonah is 4 years old (16 kg) with high-risk neuroblastoma, day 9 of induction, admitted with grade 3 mucositis. He has a hydromorphone PCA: basal 0.02 mg/kg/hr plus 0.01 mg/kg on demand every 15 minutes, and he has received 14 demands in the last 8 hours. Over the past hour he has become increasingly sleepy and is rousable only with vigorous stimulation. Respiratory rate is 10, SpO2 93% on room air, pupils are pinpoint. When roused, he rates pain 2/10 (it was 7/10 earlier). His creatinine has risen from 0.3 to 0.7 mg/dL over 3 days. He has received no other sedatives or antihistamines. His parents ask you to "give him something so he can finally sleep."
1. What is your differential, and why is "let him sleep" the wrong response?
Read the worked answer
The most likely explanation is opioid-induced sedation progressing toward respiratory depression, with a rising creatinine causing accumulation of active hydromorphone metabolites. The 14 demands in 8 hours plus a continuous basal rate in a 16 kg child with new renal impairment is a classic setup. Pinpoint pupils, bradypnea, and falling responsiveness fit.
But do not stop at the opioid. The differential for new lethargy in a neutropenic child on day 9 of induction includes sepsis, hypoglycemia, hyponatremia or other electrolyte derangement, hypercarbia, and CNS involvement. Check a glucose, review electrolytes and the most recent cultures, and assess perfusion and temperature. Untreated sepsis can present exactly this way and would be catastrophic to miss while attributing everything to analgesia.
The dangerous reasoning error is that a low pain score plus calm behavior equals comfort. Sedation precedes respiratory depression. A child who is only rousable with vigorous stimulation has already lost the protective arousal response -- this is a safety event, not a sleep problem. The parents' request is understandable, but agreeing to deepen sedation without assessment could kill him.
2. What are your immediate actions, including naloxone dosing and goals?
Read the worked answer
Sequence matters:
- Stop the PCA pump (basal and demand) and stay at the bedside. Call for help and the provider.
- Airway and breathing: position, suction ready, apply oxygen, continuous pulse oximetry and cardiorespiratory monitoring. Stimulate him and see whether he responds to voice and touch -- response to stimulation buys you time and guides how much naloxone you need.
- Get a point-of-care glucose and vital signs, including temperature and perfusion.
- Naloxone, titrated, not a full reversal dose. Give approximately 1-2 mcg/kg IV (so roughly 15-30 mcg for a 16 kg child), repeated every 2 minutes as needed, titrating to an adequate respiratory rate and saturation rather than to full wakefulness.
The goal is breathing, not alertness. Full reversal doses (0.1 mg/kg or the adult 0.4 mg ampule) will precipitate acute withdrawal, cause a pain crisis and screaming that is harmful with grade 3 mucositis, and can precipitate seizures or pulmonary edema. Because hydromorphone has a longer duration than naloxone, expect re-sedation and plan for repeated dosing or a low-dose infusion, with continuous monitoring.
- Reassess pain after stabilization and begin a deliberate plan rather than resuming the same settings.
3. Assuming he stabilizes, how do you redesign his analgesia so this does not happen again?
Read the worked answer
The problem was not that he needed opioids -- it was a fixed basal rate plus a renally cleared drug plus accumulating demands. Redesign around his actual physiology:
Change the drug to match the kidney. Hydromorphone and morphine both have active metabolites that accumulate in renal impairment. Fentanyl has no active metabolites and is the preferred opioid when creatinine is rising. Convert to a fentanyl PCA with a low or no basal rate, relying on demand dosing with a nurse-controlled component for a 4-year-old who cannot self-dose reliably.
Add multimodal adjuvants so the opioid dose can fall: scheduled acetaminophen (verify hepatic function and cumulative dosing), ketamine as an adjunct infusion or low-dose boluses (opioid-sparing and does not cause respiratory depression), topical anesthetic or coating agents for the mouth, and consider a dexmedetomidine or clonidine discussion with the team if agitation is a component.
Reset expectations and monitoring. Recheck renal function daily; reassess sedation and respiratory rate with every vital sign using a pediatric sedation scale, not just a pain score; document the sedation score alongside the pain score so a rising sedation score with a falling pain score triggers review. Consider a continuous capnography or apnea monitoring policy for high-risk patients.
Address nutrition and mucositis -- uncontrolled mucositis drives escalating demands. If he cannot drink, request nutrition and a mouth-care regimen change rather than simply titrating opioid upward.
Finally, close the loop with the family: explain that his sleepiness was a side effect that had become dangerous, and that the plan preserves comfort while protecting his breathing. Otherwise they will read the change as the team withholding pain relief.